Shuling Yan, Xia Zhao, Qiushi Xie, Weijuan Du, Qingyang Ma, Tongkang Zhu, . . . Yimin Cui. (2023). Pharmacokinetic/LDL‐C and exposure-response analysis of tafolecimab in Chinese hypercholesterolemia patients: Results from phase I, II, and III studies. Wiley.
Chicago Style (17th ed.) CitationShuling Yan, et al. Pharmacokinetic/LDL‐C and Exposure-response Analysis of Tafolecimab in Chinese Hypercholesterolemia Patients: Results from Phase I, II, and III Studies. Wiley, 2023.
MLA (9th ed.) CitationShuling Yan, et al. Pharmacokinetic/LDL‐C and Exposure-response Analysis of Tafolecimab in Chinese Hypercholesterolemia Patients: Results from Phase I, II, and III Studies. Wiley, 2023.
Warning: These citations may not always be 100% accurate.